Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1/2 1Phase 1 1

Status

Unknown 2Terminated 2Completed 1

Sponsor Class

NIH 5OTHER 1

Study Type

Interventional 5

Sponsor

Cancer Type

Gynecologic 5Gastrointestinal 1Breast 1

Conditions

Colonic Neoplasms 50Rectal Neoplasms 49Colorectal Neoplasms 36Pancreatic Neoplasms 10Unspecified Adult Solid Tumor, Protocol Specific 9Neoplasm Metastasis 8Stomach Neoplasms 7Ovarian Neoplasms 6Carcinoma, Hepatocellular 6Lymphoma, Large B-Cell, Diffuse 5Gallbladder Neoplasms 5Carcinoma, Ovarian Epithelial 5Bile Duct Neoplasms 5Burkitt Lymphoma 4Appendiceal Neoplasms 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Neuroblastoma 3Neoplasms 3Fallopian Tube Neoplasms 3Uterine Cervical Neoplasms 2Testicular Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Recurrence 2Osteosarcoma 2Optic Nerve Glioma 2Neurotoxicity Syndromes 2Neuroectodermal Tumors, Primitive, Peripheral 2Nasopharyngeal Neoplasms 2Melanoma 2Lymphoma, T-Cell, Peripheral 2

Interventions

Carboplatin 28Paclitaxel 21Cisplatin 9Topotecan 8Docetaxel 7Taxes 6Oxaliplatin 5Gemcitabine 5Chemotherapy, Adjuvant 5Bevacizumab 5aldesleukin 4Interleukin-12 Subunit p35 4Erlotinib Hydrochloride 4Drug Therapy 4Interleukin-12 3Immunohistochemistry 3Imatinib Mesylate 3Gene Expression Profiling 3Flow Cytometry 3Filgrastim 3Cyclophosphamide 3Amplified Fragment Length Polymorphism Analysis 3trioctyl phosphine oxide 2temsirolimus 2sargramostim 2oregovomab 2ixabepilone 2irofulven 2cediranib 2carboxyamido-triazole 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
NIH × Carcinoma, Ovarian Epithelial × Oxaliplatin × Clear all
NCT00313612 2015-11-27

Oxaliplatin and Topotecan in Advance Ovarian Cancer

National Cancer Institute (NCI)

Phase 2 Terminated
39 enrolled 7 charts
Gynecologic

Carcinoma, Ovarian Epithelial

NCT00004206 2014-06-24

Oxaliplatin and Fluorouracil in Treating Patients With Recurrent Ovarian Cancer

National Cancer Institute (NCI)

Phase 2 Unknown
Gynecologic

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

NCT01233505 2014-04-02

Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid Tumors

National Cancer Institute (NCI)

Phase 1 Terminated
16 enrolled
BreastGastrointestinalGynecologic

Carcinoma, Ovarian Epithelial, Breast Neoplasms, Colonic Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Stomach Neoplasms

NCT00005836 2013-06-21

Oxaliplatin in Treating Patients With Recurrent or Refractory Ovarian Epithelial Cancer or Primary Peritoneal Cancer That Has Not Responded to Platinum- Based Chemotherapy

National Cancer Institute (NCI)

Phase 2 Completed
Gynecologic

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

NCT00075543 2008-07-24

Docetaxel and Oxaliplatin in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer

National Cancer Institute (NCI)

Phase 1/2 Unknown
Gynecologic

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡